Clinical Trial Update: A Study of Everolimus in Combination With Imatinib in Metastatic Melanoma [Phase 2]

View source ↗

Summary

This update describes a terminated Phase 2 trial of everolimus in combination with imatinib for metastatic melanoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Everolimus (everolimus)
• Imatinib (imatinib)

Snippet

Sponsor: Yale University | Conditions: Metastatic Melanoma | Phase 2 | Status: TERMINATED